论文部分内容阅读
Objective: To explore the effects of ex vivo retrovirus-mediated gene transfer therapy with acidic fibroblast growth factor (aFGF) in the management of traumatic brain injury. Methods: PLXSN-SPaFGF, a recombinant retroviral vector expressing biologically